Harvard Bioscience Inc. (HBIO)
NASDAQ: HBIO
· Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM
Harvard Bioscience Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 5.55M | 4.11M | 4.57M | 4.05M | 4.25M | 4.28M | 5.34M | 4.32M | 3.79M | 4.51M | 5.14M | 4.26M | 5.43M | 7.82M | 5.55M | 6.24M | 5.82M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 34K | 1.7M | n/a | n/a | n/a | n/a | -333K | n/a | n/a | n/a | -205K | n/a | n/a | n/a |
Other Long-Term Assets | 3.52M | 2.83M | 2.92M | 3.24M | 4.79M | 6.04M | 12.57M | 11.66M | 13.45M | 13.6M | 14.32M | 8.69M | 5.26M | 12.27M | 7.8M | 810K | 812K |
Receivables | 13.48M | 14.87M | 12.83M | 12.49M | 15.31M | 16.1M | 14.98M | 16.9M | 17.74M | 16.7M | 15.02M | 17.85M | 20.27M | 21.83M | 18.34M | 17.39M | 17.07M |
Inventory | 22.82M | 23.25M | 25.99M | 25.13M | 24.14M | 24.72M | 25.82M | 26.09M | 26.86M | 26.44M | 26.12M | 29.34M | 28.71M | 27.59M | 25.98M | 24.71M | 22.68M |
Other Current Assets | 3.06M | 2.9M | 3.4M | 4.77M | 4.45M | 3.94M | 4.34M | 5.3M | 4.06M | 3.47M | 5.54M | 5.06M | 5.03M | 4.34M | 5.82M | 5.22M | 3.66M |
Total Current Assets | 44.9M | 45.12M | 46.79M | 46.43M | 48.15M | 49.04M | 50.49M | 52.62M | 52.45M | 51.12M | 51.82M | 56.5M | 59.45M | 61.58M | 55.69M | 53.56M | 49.22M |
Property-Plant & Equipment | 12.29M | 11.24M | 11.74M | 9.18M | 8.85M | 8.75M | 3.36M | 3.49M | 3.42M | 3.37M | 3.56M | 9.63M | 10.1M | 3.42M | 3.45M | 10.67M | 11.11M |
Goodwill & Intangibles | 19.09M | 67.46M | 69.78M | 70.07M | 71.38M | 73.1M | 73.32M | 75.13M | 76.26M | 77.27M | 77.31M | 80.45M | 83.23M | 85.07M | 86.93M | 88.93M | 90.11M |
Total Long-Term Assets | 34.9M | 81.53M | 84.45M | 82.48M | 85.01M | 88.33M | 89.25M | 90.28M | 93.13M | 94.24M | 95.19M | 98.78M | 98.6M | 100.76M | 98.19M | 100.41M | 102.03M |
Total Assets | 79.8M | 126.64M | 131.24M | 128.91M | 133.16M | 137.37M | 139.74M | 142.9M | 145.58M | 145.36M | 147.01M | 155.27M | 158.04M | 162.34M | 153.87M | 153.97M | 151.25M |
Account Payables | 4.81M | 4.79M | 5.28M | 5.71M | 6.04M | 5.55M | 6.27M | 4.72M | 5.98M | 6.45M | 5.88M | 6.81M | 6.22M | 4.91M | 5.62M | 7.49M | 6.42M |
Deferred Revenue | 3.43M | 5.09M | n/a | 5.12M | 5.94M | 7.71M | 4M | 3.83M | 4.12M | 3.37M | 3.64M | 3.61M | 3.96M | 4.27M | 3.62M | 3.67M | 3.64M |
Short-Term Debt | 35.96M | 36.96M | 3.61M | 3.72M | 4.92M | 7.28M | 3.47M | 3.22M | 2.97M | 3.81M | 2.72M | 4.83M | 4.87M | 3.23M | 2.47M | 4.28M | 4.03M |
Other Current Liabilities | 9.99M | 8.25M | 13.86M | 9.38M | 13.52M | 12.3M | 4.96M | 5.25M | 8.02M | 7.49M | 3.91M | 5.94M | 9.89M | 4.49M | 5.43M | 5.76M | 3.98M |
Total Current Liabilities | 55.6M | 54.96M | 22.75M | 22.62M | 25.68M | 26.54M | 24.2M | 22.94M | 23.22M | 23.25M | 21.36M | 23.35M | 27.23M | 25.32M | 23.51M | 23.27M | 20.72M |
Long-Term Debt | n/a | n/a | 34.25M | 31.96M | 31.89M | 30.7M | 35.27M | 38.2M | 41.08M | 43.01M | 46.53M | 45.76M | 46.24M | 45.09M | 42.74M | 40.92M | 41.6M |
Other Long-Term Liabilities | 1.42M | 1.25M | 1.5M | 1.61M | 1.45M | 1.48M | 892K | 1.05M | 1.45M | 1.01M | 420K | 418K | 598K | 486K | 2.47M | 2.54M | 2.85M |
Total Long-Term Liabilities | 9.36M | 8.35M | 43.17M | 39.04M | 38.67M | 37.75M | 41.24M | 44.57M | 48.02M | 49.89M | 53.67M | 54.41M | 54.44M | 53.63M | 53.48M | 52M | 53.42M |
Total Liabilities | 64.97M | 63.3M | 65.92M | 61.66M | 64.35M | 64.29M | 65.45M | 67.51M | 71.24M | 73.14M | 75.03M | 77.77M | 81.67M | 78.94M | 76.98M | 75.27M | 74.13M |
Total Debt | 44.61M | 44.49M | 45.69M | 41.45M | 41.36M | 42.77M | 38.74M | 41.42M | 44.05M | 46.82M | 49.25M | 56.4M | 57.27M | 48.33M | 45.21M | 52.17M | 52.79M |
Common Stock | 442K | 441K | 436K | 436K | 434K | 434K | 457K | 457K | 455K | 454K | 453K | 453K | 452K | 452K | 451K | 451K | 448K |
Retained Earnings | -208.35M | -158.01M | -158.03M | -153.23M | -150.3M | -145.6M | -143.79M | -142.55M | -141.57M | -142.19M | -140.52M | -137.12M | -139.55M | -132.67M | -133.63M | -133.47M | -133.06M |
Comprehensive Income | -14.36M | -15.67M | -13.06M | -14.87M | -14.77M | -14.19M | -15.28M | -14.05M | -14.65M | -15.05M | -16.18M | -13.24M | -10.73M | -10.03M | -15M | -13.87M | -14.39M |
Shareholders Equity | 14.84M | 63.34M | 65.32M | 67.25M | 68.81M | 73.07M | 74.29M | 75.39M | 74.34M | 72.22M | 71.98M | 77.5M | 76.38M | 83.4M | 76.89M | 78.7M | 77.11M |
Total Investments | n/a | n/a | n/a | 34K | 1.7M | n/a | n/a | n/a | n/a | -333K | n/a | n/a | n/a | -205K | n/a | n/a | n/a |